PHCRF (Healius) Marketable Securities : $0 Mil (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Healius Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Healius's Marketable Securities for the quarter that ended in Dec. 2024 was $0 Mil.

Healius Marketable Securities Historical Data

The historical data trend for Healius's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius Marketable Securities Chart

Healius Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Marketable Securities

Get a 7-Day Free Trial

Healius Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

Healius Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Healius (OTCPK:PHCRF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Healius Marketable Securities Related Terms

Thank you for viewing the detailed overview of Healius's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Healius Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (OTCPK:PHCRF) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

HLS:Australia

Address

161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000

Website

https://www.healius.com.au

Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.